mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |